National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol. 2007;120(5 suppl):S94-S138. Full guidelines available to http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.htm
2.
PriceJHindmarshPHughesSEfthimiouJ. Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?Eur Respir J. 2002;19:1179-1193.
3.
PriftisKNPapadimitriouAGatsopoulouEYiallourosPKFretzayasANicolaidouP. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Respir J. 2006;27:316-320.
4.
KannistoSKorppiMRemesKVoutilainenR. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab. 2000;85:652-657.
5.
BacharierLBRaissyHHWilsonLMcWilliamsBStrunkRCKellyHW. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics. 2004;113:1693-1699.
PriftisKNPapadimitriouAAnthracopoulosMBFretzayasAChrousosGP. Endocrine-immune interactions in adrenal function of asthmatic children on inhaled corticosteroids. Neuroimmunomodulation. 2009;16:333-339.
8.
ChrousosGPHarrisAG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy: 2. Review of the literature. Neuroimmunomodulation. 1998;5:288-308.
9.
PanarelliMHollowayCDFraserR. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab. 1998;83:1846-1852.
10.
ZöllnerEWLombardCGalalUHoughSIrusenEWeinbergE. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: more common than expected?J Pediatr Endocrinol Metab. 2011;24:529-534.
